BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amin M, Lam AK. Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management. Exp Mol Pathol 2015;98:411-8. [PMID: 25746664 DOI: 10.1016/j.yexmp.2015.03.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Mamoori A, Gopalan V, Smith RA, Lam AK. Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells: microRNAs and colon cancer stem cells. Biol Cell 2016;108:51-64. [DOI: 10.1111/boc.201500062] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
2 Gopalan V, Islam F, Pillai S, Tang JC, Tong DK, Law S, Chan K, Lam AK. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma. Experimental Cell Research 2016;348:146-54. [DOI: 10.1016/j.yexcr.2016.09.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
3 Rahman MA, Salajegheh A, Smith RA, Lam AK. MicroRNA-126 suppresses proliferation of undifferentiated (BRAF(V600E) and BRAF(WT)) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathway. Exp Cell Res 2015;339:342-50. [PMID: 26384552 DOI: 10.1016/j.yexcr.2015.09.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
4 Song Y, Kilburn D, Song JH, Cheng Y, Saeui CT, Cheung DG, Croce CM, Yarema KJ, Meltzer SJ, Liu KJ, Wang TH. Determination of absolute expression profiles using multiplexed miRNA analysis. PLoS One 2017;12:e0180988. [PMID: 28704432 DOI: 10.1371/journal.pone.0180988] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
5 Kestens C, Siersema PD, van Baal JW. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer. World J Gastroenterol 2016; 22(1): 1-7 [PMID: 26755856 DOI: 10.3748/wjg.v22.i1.1] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bibby BA, Reynolds JV, Maher SG. MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma. PLoS One 2015;10:e0134180. [PMID: 26221725 DOI: 10.1371/journal.pone.0134180] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
7 Yang Y, Jia B, Zhao X, Wang Y, Ye W. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis. J Cell Biochem 2019;120:10463-83. [PMID: 30582208 DOI: 10.1002/jcb.28332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
8 Chruścik A, Lam AK. Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review. Exp Mol Pathol 2015;99:393-8. [PMID: 26321247 DOI: 10.1016/j.yexmp.2015.08.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
9 Yang WZ, Yang J, Xue LP, Xiao LB, Li Y. MiR-126 overexpression inhibits high glucose-induced migration and tube formation of rhesus macaque choroid-retinal endothelial cells by obstructing VEGFA and PIK3R2. J Diabetes Complications 2017;31:653-63. [PMID: 28131600 DOI: 10.1016/j.jdiacomp.2016.12.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
10 Lao TD, Le TAH. Association Between LMP-1, LMP-2, and miR-155 Expression as Potential Biomarker in Nasopharyngeal Carcinoma Patients: A Case/Control Study in Vietnam. Genet Test Mol Biomarkers 2019;23:815-22. [PMID: 31693455 DOI: 10.1089/gtmb.2019.0089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Lee KT, Tan JK, Lam AK, Gan SY. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review. Crit Rev Oncol Hematol 2016;103:1-9. [PMID: 27179594 DOI: 10.1016/j.critrevonc.2016.04.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
12 Schoofs K, Philippron A, Avila Cobos F, Koster J, Lefever S, Anckaert J, De Looze D, Vandesompele J, Pattyn P, De Preter K. Comprehensive RNA dataset of tissue and plasma from patients with esophageal cancer or precursor lesions. Sci Data 2022;9. [DOI: 10.1038/s41597-022-01176-x] [Reference Citation Analysis]
13 Ji N, Wang Y, Gong X, Ni S, Zhang H. CircMTO1 inhibits ox-LDL-stimulated vascular smooth muscle cell proliferation and migration via regulating the miR-182-5p/RASA1 axis. Mol Med 2021;27:73. [PMID: 34238206 DOI: 10.1186/s10020-021-00330-2] [Reference Citation Analysis]
14 Ebrahimi F, Gopalan V, Wahab R, Lu C, Anthony Smith R, Lam AK. Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance. Experimental Cell Research 2015;339:333-41. [DOI: 10.1016/j.yexcr.2015.10.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
15 Ma Y, Wang B, Guo Y, Zhang Y, Huang S, Bao X, Bai M. Inhibition of miR-196a affects esophageal cancer cell growth in vitro. Biomedicine & Pharmacotherapy 2016;84:22-7. [DOI: 10.1016/j.biopha.2016.09.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
16 Maroof H, Irani S, Arianna A, Vider J, Gopalan V, Lam AK. Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers. Curr Cancer Drug Targets 2019;19:561-70. [PMID: 29956628 DOI: 10.2174/1568009618666180628154727] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
17 Gao S, Duan H, An D, Yi X, Li J, Liao C. Knockdown of long non-coding RNA LINC00467 inhibits glioma cell progression via modulation of E2F3 targeted by miR-200a. Cell Cycle 2020;19:2040-53. [PMID: 32684096 DOI: 10.1080/15384101.2020.1792127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Salajegheh A, Vosgha H, Rahman MA, Amin M, Smith RA, Lam AK. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma. Human Pathology 2016;51:75-85. [DOI: 10.1016/j.humpath.2015.12.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
19 Yang W, Ma J, Zhou W, Zhou X, Cao B, Zhang H, Zhao Q, Fan D, Hong L. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Rev Gastroenterol Hepatol 2017;11:1151-63. [PMID: 28838272 DOI: 10.1080/17474124.2017.1372189] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
20 Salajegheh A, Vosgha H, Md Rahman A, Amin M, Smith RA, Lam AK. Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer. Journal of Molecular Endocrinology 2015;55:183-96. [DOI: 10.1530/jme-15-0182] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 4.9] [Reference Citation Analysis]
21 Islam F, Gopalan V, Law S, Tang JC, Chan KW, Lam AK. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions. Hum Pathol 2017;62:141-51. [PMID: 28188753 DOI: 10.1016/j.humpath.2017.01.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
22 Neureiter D, Mayr C, Winkelmann P, Neumayer B, Klieser E, Wagner A, Hufnagl C, Emmanuel K, Holzinger J, Koch O, Kiesslich T, Varga M. Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience. Cells 2020;9:E486. [PMID: 32093260 DOI: 10.3390/cells9020486] [Reference Citation Analysis]
23 de Foucher T, Sbeih M, Uzan J, Bendifallah S, Lefevre M, Chabbert-Buffet N, Aractingi S, Uzan C, Abd Alsalam I, Mitri R, Fontaine RH, Daraï E, Haddad B, Méhats C, Ballester M, Canlorbe G, Touboul C. Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer. J Transl Med 2018;16:131. [PMID: 29783999 DOI: 10.1186/s12967-018-1515-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Amin M, Islam F, Gopalan V, Lam AK. Detection and Quantification of MicroRNAs in Esophageal Adenocarcinoma. In: Lam AK, editor. Esophageal Adenocarcinoma. New York: Springer; 2018. pp. 257-68. [DOI: 10.1007/978-1-4939-7734-5_22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]